Your session is about to expire
← Back to Search
Digital Intervention for Binge Eating Disorder in Black Women
N/A
Waitlist Available
Led By Rachel Goode, PhD,MPH
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial found Black women are more likely to binge eat & struggle to get effective treatment. To reduce weight-related concerns, culturally-relevant treatments for binge eating must be available to Black women.
Who is the study for?
This trial is for Black women over 18 with obesity (BMI ≥ 30) who binge eat at least once a week and live or work within 30 miles of Kannapolis, NC. They must use a smartphone and complete a questionnaire. It's not for those in other weight programs, using drugs/alcohol heavily, pregnant, treating substance abuse/eating disorders, or with anorexia history.
What is being tested?
'Centering Appetite' is being tested as a culturally-relevant digital treatment to help Black women manage obesity and binge eating. The study aims to address the high rates of obesity by focusing on reducing binge eating behaviors through accessible technology.
What are the potential side effects?
Since 'Centering Appetite' is a behavioral intervention rather than medication, side effects may include emotional discomfort or stress due to changes in eating habits but are generally considered low-risk compared to drug treatments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Attendance: Percentage of Intervention Sessions Attended
Feasibility (Recruitment): Total Number of Eligible Adults Enrolled in the Study
Retention: Percentage of Participants Retained in the Study
Secondary study objectives
Change from Baseline to Month 3 in weight regain
Change from Baseline to Month 6 in weight regain
Change in number of Binge Eating Episodes from Baseline to Month 3
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Centering Appetite Intervention, Then Attention- Control GroupExperimental Treatment1 Intervention
Participants randomized to the attention-control group will participate remotely via a smartphone app and online lessons. The intervention will build participants' self-efficacy to reduce binge eating and to assist them in preventing weight gain.
Group II: Attention- Control Group, Then Centering Appetite InterventionActive Control1 Intervention
Participants randomized to the centering appetite intervention group will receive weekly psychoeducation emails about general wellness topics, discussion of binge eating, diet, and physical activity.
Find a Location
Who is running the clinical trial?
University of North Carolina, Chapel HillLead Sponsor
1,561 Previous Clinical Trials
4,298,721 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,455 Previous Clinical Trials
4,335,048 Total Patients Enrolled
Rachel Goode, PhD,MPHPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am receiving treatment for eating difficulties.I am over 18 years old.I have a history of anorexia.
Research Study Groups:
This trial has the following groups:- Group 1: Centering Appetite Intervention, Then Attention- Control Group
- Group 2: Attention- Control Group, Then Centering Appetite Intervention
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.